相关实验视频

Updated: May 12, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

肺癌脑转移中的免疫疗法

Eunice Paisana¹, Rita Cascão¹, Magda Alvoeiro²

¹GIMM - Gulbenkian Institute for Molecular Medicine, Lisboa, Portugal.

NPJ precision oncology

|May 6, 2025

概括

大脑转移 (BM) 在非小细胞肺癌 (NSCLC) 中很常见,导致显著的死亡率. 本综述研究了NSCLC大脑转移的免疫环境,免疫疗法和生物标志物.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
神经学神经学

背景情况:

大脑转移 (BM) 是非小细胞肺癌 (NSCLC) 的常见和严重并发症.
目前对NSCLC脑转移的治疗面临挑战,原因是血脑屏障和瘤异质性.
了解大脑转移的独特免疫微环境对于开发有效疗法至关重要.

研究的目的:

审查目前对非小细胞肺癌脑转移的免疫场景的理解.
探索针对大脑转移的新兴免疫治疗策略.
确定有前途的生物标志物,用于预测脑转移性NSCLC患者对治疗的反应.

主要方法:

临床前和临床研究的文献综述.
对脑转移的瘤微环境研究的分析.
综合关于免疫治疗方法和生物标志物开发的数据.

主要成果:

大脑转移的免疫场景与原发性瘤有很大不同,影响治疗反应.
一些新的免疫治疗策略正在研究中,在临床前模型中显示出潜力.
生物标志物正在出现,可以帮助个性化治疗NSCLC患者的大脑转移.

结论:

NSCLC脑转移的免疫微环境提供了独特的治疗机会.
准免疫系统为改善脑转移患者的治疗结果提供了一个有希望的途径.
对生物标志物的进一步研究对于优化免疫疗法疗效至关重要.

更多相关视频

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.